Hepatic Metastases Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Metastases to liver / Liver Metastases / Metastatic neoplasm of liver / Cancer of liver, secondary / Metastasis to liver / Malignant neoplasm of liver, specified as secondary

IndicationStatusPhase
DBCOND0032606 (Hepatic Metastases)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02509507Trial to Evaluate the Safety ofTalimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic PembrolizumabTreatment